Cargando…
Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis
The in vivo correct QT (QTc) assay is used by the pharmaceutical industry to characterize the potential for delayed ventricular repolarization and is a core safety assay mentioned in International Conference on Harmonization (ICH) S7B guideline. The typical telemetry study involves a dose‐response a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604216/ https://www.ncbi.nlm.nih.gov/pubmed/34173339 http://dx.doi.org/10.1111/cts.13103 |
_version_ | 1784601911388798976 |
---|---|
author | Chui, Ray W. Baublits, Joel Chandra, Fiona A. Jones, Zack W. Engwall, Michael J. Vargas, Hugo M. |
author_facet | Chui, Ray W. Baublits, Joel Chandra, Fiona A. Jones, Zack W. Engwall, Michael J. Vargas, Hugo M. |
author_sort | Chui, Ray W. |
collection | PubMed |
description | The in vivo correct QT (QTc) assay is used by the pharmaceutical industry to characterize the potential for delayed ventricular repolarization and is a core safety assay mentioned in International Conference on Harmonization (ICH) S7B guideline. The typical telemetry study involves a dose‐response analysis of QTc intervals over time using a crossover (CO) design. This method has proven utility but does not include direct integration of pharmacokinetic (PK) data. An alternative approach has been validated and is used routinely in the clinical setting that pairs pharmacodynamic (PD) responses with PK exposure (e.g., concentration‐QTc (C‐QTc) analysis. The goal of our paper was to compare the QTc sensitivity of two experimental approaches in the conscious dog and non‐human primate (NHP) QTc assays. For timepoint analysis, a conventional design using eight animals (8 × 4 CO) to detect moxifloxacin‐induced QTc prolongation was compared to a PK/PD design in a subset (N = 4) of the same animals. The findings demonstrate that both approaches are equally sensitive in detecting threshold QTc prolongation on the order of 10 ms. Both QTc models demonstrated linearity in the QTc prolongation response to moxifloxacin dose escalation (6 to 46 ms). Further, comparison with human QTc findings with moxifloxacin showed agreement and consistent translation across the three species: C‐QTc slope values were 0.7‐ (dog) and 1.2‐ (NHP) fold of the composite human value. In conclusion, our data show that dog and NHP QTc telemetry with an integrated PK arm (C‐QTc) has the potential to supplement clinical evaluation and improve integrated QTc risk assessment. |
format | Online Article Text |
id | pubmed-8604216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86042162021-11-24 Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis Chui, Ray W. Baublits, Joel Chandra, Fiona A. Jones, Zack W. Engwall, Michael J. Vargas, Hugo M. Clin Transl Sci Research The in vivo correct QT (QTc) assay is used by the pharmaceutical industry to characterize the potential for delayed ventricular repolarization and is a core safety assay mentioned in International Conference on Harmonization (ICH) S7B guideline. The typical telemetry study involves a dose‐response analysis of QTc intervals over time using a crossover (CO) design. This method has proven utility but does not include direct integration of pharmacokinetic (PK) data. An alternative approach has been validated and is used routinely in the clinical setting that pairs pharmacodynamic (PD) responses with PK exposure (e.g., concentration‐QTc (C‐QTc) analysis. The goal of our paper was to compare the QTc sensitivity of two experimental approaches in the conscious dog and non‐human primate (NHP) QTc assays. For timepoint analysis, a conventional design using eight animals (8 × 4 CO) to detect moxifloxacin‐induced QTc prolongation was compared to a PK/PD design in a subset (N = 4) of the same animals. The findings demonstrate that both approaches are equally sensitive in detecting threshold QTc prolongation on the order of 10 ms. Both QTc models demonstrated linearity in the QTc prolongation response to moxifloxacin dose escalation (6 to 46 ms). Further, comparison with human QTc findings with moxifloxacin showed agreement and consistent translation across the three species: C‐QTc slope values were 0.7‐ (dog) and 1.2‐ (NHP) fold of the composite human value. In conclusion, our data show that dog and NHP QTc telemetry with an integrated PK arm (C‐QTc) has the potential to supplement clinical evaluation and improve integrated QTc risk assessment. John Wiley and Sons Inc. 2021-07-14 2021-11 /pmc/articles/PMC8604216/ /pubmed/34173339 http://dx.doi.org/10.1111/cts.13103 Text en © 2021 Amgen Inc. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Chui, Ray W. Baublits, Joel Chandra, Fiona A. Jones, Zack W. Engwall, Michael J. Vargas, Hugo M. Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title | Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title_full | Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title_fullStr | Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title_full_unstemmed | Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title_short | Evaluation of moxifloxacin in canine and non‐human primate telemetry assays: Comparison of QTc interval prolongation by timepoint and concentration‐QTc analysis |
title_sort | evaluation of moxifloxacin in canine and non‐human primate telemetry assays: comparison of qtc interval prolongation by timepoint and concentration‐qtc analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604216/ https://www.ncbi.nlm.nih.gov/pubmed/34173339 http://dx.doi.org/10.1111/cts.13103 |
work_keys_str_mv | AT chuirayw evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis AT baublitsjoel evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis AT chandrafionaa evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis AT joneszackw evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis AT engwallmichaelj evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis AT vargashugom evaluationofmoxifloxacinincanineandnonhumanprimatetelemetryassayscomparisonofqtcintervalprolongationbytimepointandconcentrationqtcanalysis |